Ruyue Xu

430 citations
19 papers · 297 indexed · h-index 11
Topics
Cancer Mechanisms and Therapy (5 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)Cytokine Signaling Pathways and Interactions (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Ruyue Xu

19 papers receiving 295 citations

Peers

Ruyue Xu
Comparison fields: 5 of 70
  • Molecular Biology 154
  • Pathology and Forensic Medicine 71
  • Oncology 59
  • Cancer Research 59
  • Pulmonary and Respiratory Medicine 42
Replace C.-H. Chou with:
C.-H. Chou Taiwan
Gengxia Yang China
Yongfang Ma China
Yinci Zhang China
Zhijian Yang China
Xinshuai Wang China
Tingting Feng China
Seung Moo Noh South Korea
Ruyue Xu relative to C.-H. Chou Taiwan C.-H. Chou's profile →
Citations per field
00.5×10×15×20×25×
C.-H. Chou · 1×
Citations per year

Countries citing papers authored by Ruyue Xu

Since Specialization
Citations

This map shows the geographic impact of Ruyue Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyue Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyue Xu more than expected).

Fields of papers citing papers by Ruyue Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyue Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyue Xu. The network helps show where Ruyue Xu may publish in the future.

Co-authorship network of co-authors of Ruyue Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyue Xu. A scholar is included among the top collaborators of Ruyue Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyue Xu. Ruyue Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 1
2 7
3 32
4 4
5 25
6 9
7 18
8 19
9 2
10 22
11 28
12 8
13 14
14 17
15 1
16 5
17
PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.
36
18
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
29
19
BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.
20

About Ruyue Xu

Ruyue Xu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 19 papers that have together received 297 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Hepatology (41 citations), Pathology and Forensic Medicine (71 citations) and Cancer Research (59 citations). Ruyue Xu has collaborated with scholars based in China and United States. Frequent co-authors include Amin Li, Yongfang Ma, Weiya Cao, Shuping Zhou, Yinci Zhang, Xinkuang Liu, Song Li, Xiaolong Tang, Xueke Liu and Shuyu Cai. Their work appears in journals such as Frontiers in Microbiology, Ecotoxicology and Environmental Safety and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026